Advertisement
Entire Site
Articles/Fact Sheets
Ask the Experts
Conference Coverage
HIV/AIDS Basics & Prevention
HIV/AIDS Basics & Prevention
Basics & Prevention: Home
HIV/AIDS Basics
HIV Prevention
HIV Testing
Who Gets HIV/AIDS?
Myths About HIV/AIDS
More ...
Just Diagnosed
Just Diagnosed
Just Diagnosed: Home
Choosing a Physician
Coping
HIV Hotlines & Orgs
Telling Others
More ...
HIV Treatment
HIV Treatment
HIV Treatment: Home
Drug Resistance
HIV Medications
Side Effects & Health Problems
Starting Treatment
Women & Pregnancy
More ...
Living With HIV
Living With HIV
Living With HIV: Home
Arts & Entertainment
Beyond Medications
Inspiring Stories
Mental Health
More ...
AIDS Policy & Activism
AIDS Policy & Activism
HIV Policy & Activism: Home
Activist Central
Medicine Recycling
U.S.-Specific News
Developing World News
More ...
HIV Around the World
HIV Around the World
HIV Around the World: Home
Africa
Asia
Latin America
U.S. and Canada
Western Europe
More ...
Conference Coverage
Conference Coverage
Conference Coverage: Home
CROI 2009
ICAAC/IDSA 2008
Previous Conferences
Upcoming Conferences
More ...
E-Mail
Glossary
Share
Hivid (Zalcitabine, ddC)
See also:
Drug Interactions
|
Medication Side Effects
|
All HIV Medications
Show Archived (Historical) Articles
Brand Name:
Hivid
Generic Name:
Zalcitabine, ddC
Adult Single Dose:
One 0.75-mg tablet (every 8 hours)
Food & Liquid Restrictions:
Take on an empty stomach
Drug Class:
NRTI
An Overview of Hivid (Zalcitabine, ddC)
(Regularly Updated)
To read PDF,
click here
From
U.S. National Institutes of Health
Zalcitabine (Hivid, ddC)
(November 7, 2007)
To read PDF,
click here
From
AIDS InfoNet
ddC (Hivid)
(August 15, 2006)
From AIDS Treatment Data Network
Patient Information About Hivid (Zalcitabine, ddC) (PDF)
(September 2002)
From Roche
E-Mail
Glossary
Share
Advertisement